Discovery and development of the G-rich oligonucleotide AS1411 as a novel treatment for cancer
Tóm tắt
Từ khóa
Tài liệu tham khảo
Agrawal, 1996, Effect of G-rich sequences on the synthesis, purification, hybridization, cell uptake and hemolytic activity of oligonucleotides, Bioorgan. Med. Chem. Lett., 6, 2219, 10.1016/0960-894X(96)00403-9
Akhtar, 2002, Sequence and chemistry requirements for a novel aptameric oligonucleotide inhibitor of EGF receptor tyrosine kinase activity, Biochem. Pharmacol., 63, 2187, 10.1016/S0006-2952(02)00985-1
Alete, 2006, Cell surface nucleolin on developing muscle is a potential ligand for the axonal receptor protein tyrosine phosphatase-sigma, FEBS J., 273, 4668, 10.1111/j.1742-4658.2006.05471.x
Anselmet, 2002, Non-antisense cellular responses to oligonucleotides, FEBS Lett., 510, 175, 10.1016/S0014-5793(01)03248-3
Aoki, 2007, Telomere 3′ overhang-specific DNA oligonucleotides induce autophagy in malignant glioma cells, FASEB J., 21, 2918, 10.1096/fj.06-6941com
Balasubramanian, 1998, Interferon-gamma-inhibitory oligodeoxynucleotides alter the conformation of interferon-gamma, Mol. Pharmacol., 53, 926
Barel, 2008, A novel receptor–ligand pathway for entry of Francisella tularensis in monocyte-like THP-1 cells: interaction between surface nucleolin and bacterial elongation factor Tu, BMC Microbiol., 8, 145, 10.1186/1471-2180-8-145
Barnhart, 2004, AGRO100: the translation from lab to clinic of a tumor-targeted nucleic acid aptamer, J. Clin. Oncol., 22, 226S, 10.1200/jco.2004.22.14_suppl.3126
Bartz, 2004, Poly-guanosine strings improve cellular uptake and stimulatory activity of phosphodiester CpG oligonucleotides in human leukocytes, Vaccine, 23, 148, 10.1016/j.vaccine.2004.05.020
Basner-Tschakarjan, 2004, Uptake and trafficking of DNA in keratinocytes: evidence for DNA-binding proteins, Gene Ther., 11, 765, 10.1038/sj.gt.3302221
Bates, 1999, Antiproliferative activity of G-rich oligonucleotides correlates with protein binding, J. Biol. Chem., 274, 26369, 10.1074/jbc.274.37.26369
Bates, 2008, Method for the diagnosis and prognosis of malignant diseases, United States Patent, 7, 928
Beltinger, 1995, Binding, uptake, and intracellular trafficking of phosphorothioate-modified oligodeoxynucleotides, J. Clin. Invest., 95, 1814, 10.1172/JCI117860
Benimetskaya, 1997, Formation of a G-tetrad and higher order structures correlates with biological activity of the RelA (NF-kappaB p65) ‘antisense’ oligodeoxynucleotide, Nucleic Acids Res., 25, 2648, 10.1093/nar/25.13.2648
Biessen, 1998, Liver uptake of phosphodiester oligodeoxynucleotides is mediated by scavenger receptors, Mol. Pharmacol., 53, 262, 10.1124/mol.53.2.262
Bishop, 1996, Intramolecular G-quartet motifs confer nuclease resistance to a potent anti-HIV oligonucleotide, J. Biol. Chem., 271, 5698, 10.1074/jbc.271.10.5698
Biyani, 2005, Structural characterization of ultra-stable higher-ordered aggregates generated by novel guanine-rich DNA sequences, Gene., 364, 130, 10.1016/j.gene.2005.05.041
Borer, 1996, Major nucleolar proteins shuttle between nucleus and cytoplasm, Cell, 56, 379, 10.1016/0092-8674(89)90241-9
Bose, 2004, Role of nucleolin in human parainfluenza virus type 3 infection of human lung epithelial cells, J. Virol., 78, 8146, 10.1128/JVI.78.15.8146-8158.2004
Burgess, 1995, The antiproliferative activity of c-myb and c-myc antisense oligonucleotides in smooth muscle cells is caused by a nonantisense mechanism, Proc. Natl. Acad. Sci.U.S. A., 92, 4051, 10.1073/pnas.92.9.4051
Callebaut, 1998, Identification of V3 loop-binding proteins as potential receptors implicated in the binding of HIV particles to CD4(+) cells, J. Biol. Chem., 273, 21697, 10.1074/jbc.273.34.21988
Cao, 2006, Nuclease resistance of telomere-like oligonucleotides monitored in live cells by fluorescence anisotropy imaging, Anal. Chem., 78, 1478, 10.1021/ac0517601
Carpentier, 2005, Nucleolin undergoes partial N- and O-glycosylations in the extranuclear cell compartment, Biochemistry, 44, 5804, 10.1021/bi047831s
Chen, 2007, Activity and mechanism of action of AS1411 in acute myeloid leukemia cells, Blood, 110, 479A, 10.1182/blood.V110.11.1604.1604
Chen, 2008, Cell surface nucleolin serves as receptor for DNA nanoparticles composed of pegylated polylysine and DNA, Mol. Ther., 16, 333, 10.1038/sj.mt.6300365
Christian, 2003, Nucleolin expressed at the cell surface is a marker of endothelial cells in angiogenic blood vessels, J. Cell Biol., 163, 871, 10.1083/jcb.200304132
Cogoi, 2004, Antiproliferative activity of a triplex-forming oligonucleotide recognizing a Ki-ras polypurine/polypyrimidine motif correlates with protein binding, Cancer Gene Ther., 11, 465, 10.1038/sj.cgt.7700722
Cogoi, 2004, G-rich oligonucleotide inhibits the binding of a nuclear protein to the Ki-ras promoter and strongly reduces cell growth in human carcinoma pancreatic cells, Biochemistry, 43, 2512, 10.1021/bi035754f
Corrias, 1998, Interaction of human plasma membrane proteins and oligodeoxynucleotides, Biochem. Pharmacol., 55, 1221, 10.1016/S0006-2952(97)00595-9
Dalpke, 2002, Phosphodiester CpG oligonucleotides as adjuvants: polyguanosine runs enhance cellular uptake and improve immunostimulative activity of phosphodiester CpG oligonucleotides in vitro and in vivo, Immunology, 106, 102, 10.1046/j.1365-2567.2002.01410.x
Dapas, 2003, Identification of different isoforms of eEF1A in the nuclear fraction of human T-lymphoblastic cancer cell line specifically binding to aptameric cytotoxic GT oligomers, Eur. J. Biochem., 270, 3251, 10.1046/j.1432-1033.2003.03713.x
Dapić, 2002, Antiproliferative activity of G-quartet-forming oligonucleotides with backbone and sugar modifications, Biochemistry, 41, 3676, 10.1021/bi0119520
Dapić, 2003, Biophysical and biological properties of quadruplex oligodeoxyribonucleotides, Nucleic Acids Res., 31, 2097, 10.1093/nar/gkg316
de Fougerolles, 2007, Interfering with disease: a progress report on siRNA-based therapeutics, Nat. Rev. Drug Discov., 6, 443, 10.1038/nrd2310
Dempsey, 1999, G4 DNA binding by LR1 and its subunits, nucleolin and hnRNP D, a role for G–G pairing in immunoglobulin switch recombination, J. Biol. Chem., 274, 1066, 10.1074/jbc.274.2.1066
Deng, 1996, Internalization of anti-nucleolin antibody into viable HEp-2 cells, Mol. Biol. Rep., 23, 191, 10.1007/BF00351168
Destouches, 2008, Suppression of tumor growth and angiogenesis by a specific antagonist of the cell-surface expressed nucleolin, PLoS ONE, 3, e2518, 10.1371/journal.pone.0002518
de Verdugo, 1995, Characterization of a 100-kilodalton binding protein for the six serotypes of coxsackie B viruses, J. Virol., 69, 6751, 10.1128/JVI.69.11.6751-6757.1995
Dickinson, 1995, Nucleolin is a matrix attachment region DNA-binding protein that specifically recognizes a region with high base-unpairing potential, Mol. Cell Biol., 15, 456, 10.1128/MCB.15.1.456
Di Segni, 2008, Identification of nucleolin as new ErbB receptors-interacting protein, PLoS ONE, 3, e2310, 10.1371/journal.pone.0002310
Duca, 2008, The triple helix: 50 years later, the outcome, Nucleic Acids Res., 36, 5123, 10.1093/nar/gkn493
Dumler, 1999, Urokinase-induced mitogenesis is mediated by casein kinase 2 and nucleolin, Curr. Biol., 9, 1468, 10.1016/S0960-9822(00)80116-5
Eller, 2002, Induction of apoptosis by telomere 3′ overhang-specific DNA, Exp. Cell Res., 276, 185, 10.1006/excr.2002.5531
Eller, 2003, Induction of a p95/Nbs1-mediated S phase checkpoint by telomere 3′ overhang specific DNA, FASEB J., 17, 152, 10.1096/fj.02-0197com
Fennewald, 1995, Inhibition of herpes simplex virus in culture by oligonucleotides composed entirely of deoxyguanosine and thymidine, Antiviral Res., 26, 37, 10.1016/0166-3542(94)00064-F
Filion, 2003, Development of short non-CpG phosphodiester oligonucleotides as immune stimulatory agents, Vaccine, 21, 983, 10.1016/S0264-410X(02)00549-2
Filion, 2004, Development of immunomodulatory six base-length non-CpG motif oligonucleotides for cancer vaccination, Vaccine, 22, 2480, 10.1016/j.vaccine.2003.11.072
Fu, 2005, Proteomic evidence for roles for nucleolin and poly[ADP-ribosyl] transferase in drug resistance, J. Proteome Res., 4, 1583, 10.1021/pr0501158
Gewirtz, 2007, On future's doorstep: RNA interference and the pharmacopeia of tomorrow, J. Clin. Invest., 117, 3612, 10.1172/JCI34274
Girvan, A.C., 2006. Mechanistic studies of guanine-rich oligonucleotides (Doctoral Dissertation), University of Louisville Electronic Theses and Dissertations.
Girvan, 2006, AGRO100 inhibits activation of nuclear factor-kappaB (NF-kappaB) by forming a complex with NF-kappaB essential modulator (NEMO) and nucleolin, Mol. Cancer Ther., 5, 1790, 10.1158/1535-7163.MCT-05-0361
Goodchild, 2007, Cytotoxic G-rich oligodeoxynucleotides: putative protein targets and required sequence motif, Nucleic Acids Res., 35, 4562, 10.1093/nar/gkm465
Gozar, 2008, Dz13, a DNAzyme targeting c-jun, induces off-target cytotoxicity in endothelial cells with features of nonapoptotic programmed cell death, Oligonucleotides, 18, 257, 10.1089/oli.2008.0139
Grinstein, 2002, Nucleolin as activator of human papillomavirus type 18 oncogene transcription in cervical cancer, J. Exp. Med., 196, 1067, 10.1084/jem.20011053
Grinstein, 2006, Cell cycle-controlled interaction of nucleolin with the retinoblastoma protein and cancerous cell transformation, J. Biol. Chem., 281, 22223, 10.1074/jbc.M513335200
Hanakahi, 1999, High affinity interactions of nucleolin with G–G-paired rDNA, J. Biol. Chem., 274, 15908, 10.1074/jbc.274.22.15908
Harms, 2001, Identification of nucleolin as a new L-selectin ligand, Biochem. J., 360, 531, 10.1042/0264-6021:3600531
Hirano, 2005, A multifunctional shuttling protein nucleolin is a macrophage receptor for apoptotic cells, J. Biol. Chem., 280, 39284, 10.1074/jbc.M505275200
Homann, 2006, Serum-stable RNA aptamers to an invariant surface domain of live African trypanosomes, Comb. Chem. High Throughput Screen, 9, 491, 10.2174/138620706777935324
Hovanessian, 2000, The cell-surface-expressed nucleolin is associated with the actin cytoskeleton, Exp. Cell Res., 261, 312, 10.1006/excr.2000.5071
Huang, 2006, The angiogenic function of nucleolin is mediated by vascular endothelial growth factor and nonmuscle myosin, Blood, 107, 3564, 10.1182/blood-2005-07-2961
Hughes, 1994, Influence of base composition on membrane binding and cellular uptake of 10-mer phosphorothioate oligonucleotides in Chinese hamster ovary (CHRC5) cells, Antisense Res. Dev., 4, 211, 10.1089/ard.1994.4.211
Huizenga, 1995, A DNA aptamer that binds adenosine and ATP, Biochemistry, 34, 656, 10.1021/bi00002a033
Iliakis, 2004, Evidence for an S-phase checkpoint regulating DNA replication after heat shock: a review, Int. J. Hyperthermia, 20, 240, 10.1080/02656730310001656379
Ireson, 2006, Discovery and development of anticancer aptamers, Mol. Cancer Ther., 5, 2957, 10.1158/1535-7163.MCT-06-0172
Ishikawa, 1993, Nuclear proteins that bind the pre-mRNA 3′ splice site sequence r(UUAG/G) and the human telomeric DNA sequence d(TTAGGG)n, Mol. Cell Biol., 13, 4301, 10.1128/MCB.13.7.4301
Jiang, 2008, Mycoplasma infection transforms normal lung cells and induces bone morphogenetic protein 2 expression by post-transcriptional mechanisms, J. Cell Biochem., 104, 580, 10.1002/jcb.21647
Jing, 2004, G-quartet oligonucleotides: a new class of signal transducer and activator of transcription 3 inhibitors that suppresses growth of prostate and breast tumors through induction of apoptosis, Cancer Res., 64, 6603, 10.1158/0008-5472.CAN-03-4041
Jing, 2006, Targeting signal transducer and activator of transcription 3 with G-quartet oligonucleotides: a potential novel therapy for head and neck cancer, Mol. Cancer Ther., 5, 279, 10.1158/1535-7163.MCT-05-0302
Joo, 2005, Nucleolin: acharan sulfate-binding protein on the surface of cancer cells, Glycobiology, 15, 1, 10.1093/glycob/cwh132
Jordan, 1994, Major cell surface-located protein substrates of an ecto-protein kinase are homologs of known nuclear proteins, Biochemistry, 33, 14696, 10.1021/bi00253a007
Juliano, 2008, Mechanisms and strategies for effective delivery of antisense and siRNA oligonucleotides, Nucleic Acids Res., 36, 4158, 10.1093/nar/gkn342
Kaur, 2004, Single-base oligodeoxyguanosine-binding proteins on nonspecific cytotoxic cells: identification of a new class of pattern-recognition receptors, Scand. J. Immunol., 60, 238, 10.1111/j.0300-9475.2004.01455.x
Kibbey, 1995, A 110-kD nuclear shuttling protein, nucleolin, binds to the neurite-promoting IKVAV site of laminin-1, J. Neurosci. Res., 42, 314, 10.1002/jnr.490420305
Kim, 2005, Novel checkpoint response to genotoxic stress mediated by nucleolin-replication protein a complex formation, Mol. Cell Biol., 25, 2463, 10.1128/MCB.25.6.2463-2474.2005
Kochetkova, 1997, Deoxyribonucleic acid triplex formation inhibits granulocyte macrophage colony-stimulating factor gene expression and suppresses growth in juvenile myelomonocytic leukemic cells, J. Clin. Invest., 99, 3000, 10.1172/JCI119495
Krantz, 1995, Purification and partial amino acid sequencing of a fructosyllysine-specific binding protein from cell membranes of the monocyte-like cell line U937, Biochim. Biophys. Acta., 1266, 109, 10.1016/0167-4889(95)00028-Q
Krieg, 2008, Toll-like receptor 9 (TLR9) agonists in the treatment of cancer, Oncogene, 27, 161, 10.1038/sj.onc.1210911
Laber, 2004, A phase I study of AGRO100 in advanced cancer, J. Clin. Oncol., 22, 3112, 10.1200/jco.2004.22.14_suppl.3112
Laber, 2005, Update on the first phase I study of AGRO100 in advanced cancer, J. Clin. Oncol., 23, 3064, 10.1200/jco.2005.23.16_suppl.3064
Laber, 2005, Long term clinical response in renal cell carcinoma patients treated with quadruplex forming oligonucleotides, Clin. Cancer Res., 11, 9088S
Laber, 2007, Pharmacokinetics of the anti-nucleolin aptamer AS1411 in a phase I study, Mol. Cancer Ther., 6, 3574S
Lang, 1999, Guanosine-rich oligodeoxynucleotides induce proliferation of macrophage progenitors in cultures of murine bone marrow cells, Eur. J. Immunol., 29, 3496, 10.1002/(SICI)1521-4141(199911)29:11<3496::AID-IMMU3496>3.0.CO;2-3
Larrucea, 1998, Cellular adhesion mediated by factor J, a complement inhibitor. Evidence for nucleolin involvement, J. Biol. Chem., 273, 31718, 10.1074/jbc.273.48.31718
Lauhon, 1995, RNA aptamers that bind flavin and nicotinamide redox cofactors, J. Am. Chem. Soc., 117, 1246, 10.1021/ja00109a008
Lee, 2000, Effects of a hexameric deoxyriboguanosine run conjugation into CpG oligodeoxynucleotides on their immunostimulatory potentials, J. Immunol., 165, 3631, 10.4049/jimmunol.165.7.3631
Legrand, 2004, Surface nucleolin participates in both the binding and endocytosis of lactoferrin in target cells, Eur. J. Biochem., 271, 303, 10.1046/j.1432-1033.2003.03929.x
Lévesque, 2007, In vitro selection and characterization of RNA aptamers binding thyroxine hormone, Biochem. J., 403, 129, 10.1042/BJ20061216
Li, 2003, Evidence that exposure of the telomere 3′ overhang sequence induces senescence, Proc. Natl. Acad. Sci. U.S.A., 100, 527, 10.1073/pnas.0235444100
Li, 2004, Signaling pathway requirements for induction of senescence by telomere homolog oligonucleotides, Exp. Cell Res., 301, 189, 10.1016/j.yexcr.2004.08.019
Li, 2007, Aptamer-based label-free method for hemin recognition and DNA assay by capillary electrophoresis with chemiluminescence detection, Anal. Bioanal. Chem., 389, 887, 10.1007/s00216-007-1487-5
Macaya, 1993, Thrombin-binding DNA aptamer forms a unimolecular quadruplex structure in solution, Proc. Natl. Acad. Sci. U.S.A., 90, 3745, 10.1073/pnas.90.8.3745
Maltese, 1995, Sequence context of antisense RelA/NF-kappa B phosphorothioates determines specificity, Nucleic Acids Res., 23, 1146, 10.1093/nar/23.7.1146
Marwaha, 2005, T-oligo treatment decreases constitutive and UVB-induced COX-2 levels through p53- and NFkappaB-dependent repression of the COX-2 promoter, J. Biol. Chem., 280, 32379, 10.1074/jbc.M503245200
Matsugami, 2008, Structural analysis of r(GGA)4 found in RNA aptamer for bovine prion protein, Nucleic Acids Symp. Ser., 52, 179, 10.1093/nass/nrn091
McMicken, 2003, Antiproliferative activity of G-quartet-containing oligonucleotides generated by a novel single-stranded DNA expression system, Cancer Gene Ther., 10, 867, 10.1038/sj.cgt.7700652
Miller, 2006, Extended phase I study of AS1411 in renal and non-small cell lung cancers, Ann. Oncol., 17, 147
Mongelard, 2007, Nucleolin: a multiFACeTed protein, Trends Cell Biol., 17, 80, 10.1016/j.tcb.2006.11.010
Morassutti, 1999, Effect of oligomer length and base substitutions on the cytotoxic activity and specific nuclear protein recognition of GTn oligonucleotides in the human leukemic CCRF-CEM cell line, Nucleosides Nucleotides, 18, 1711, 10.1080/07328319908044830
Mori, 2004, RNA aptamers selected against the receptor activator of NF-kappaB acquire general affinity to proteins of the tumor necrosis factor receptor family, Nucleic Acids Res., 32, 6120, 10.1093/nar/gkh949
Nakanishi, 2005, Nuclear factor-kappaB inhibitors as sensitizers to anticancer drugs, Nat. Rev. Cancer, 5, 297, 10.1038/nrc1588
Nimjee, 2005, Aptamers: an emerging class of therapeutics, Annu. Rev. Med., 56, 555, 10.1146/annurev.med.56.062904.144915
Nisole, 2002, The anti-HIV pentameric pseudopeptide HB-19 binds the C-terminal end of nucleolin and prevents anchorage of virus particles in the plasma membrane of target cells, J. Biol. Chem., 277, 20877, 10.1074/jbc.M110024200
Ohashi, 2007, Features that determine telomere homolog oligonucleotide-induced therapeutic DNA damage-like responses in cancer cells, J. Cell Physiol., 210, 582, 10.1002/jcp.20848
Ojwang, 1994, Inhibition of human immunodeficiency virus type 1 activity in vitro by oligonucleotides composed entirely of guanosine and thymidine, J. Acquir. Immune Defic. Syndr., 7, 560
Ojwang, 1994, Inhibition of Friend murine leukemia virus activity by guanosine/thymidine oligonucleotides, Antiviral Res., 25, 27, 10.1016/0166-3542(94)90091-4
Otake, 2007, Overexpression of nucleolin in chronic lymphocytic leukemia cells induces stabilization of bcl2 mRNA, Blood, 109, 3069, 10.1182/blood-2006-08-043257
Pal, 2004, Human SWI/SNF-associated PRMT5 methylates histone H3 arginine 8 and negatively regulates expression of ST7 and NM23 tumor suppressor genes, Mol. Cell Biol., 24, 9630, 10.1128/MCB.24.21.9630-9645.2004
Patole, 2005, G-rich DNA suppresses systemic lupus, J. Am. Soc. Nephrol., 16, 3273, 10.1681/ASN.2005060658
Pestourie, 2005, Aptamers against extracellular targets for in vivo applications, Biochimie, 87, 921, 10.1016/j.biochi.2005.04.013
Phan, 2005, An interlocked dimeric parallel-stranded DNA quadruplex: a potent inhibitor of HIV-1 integrase, Proc. Natl. Acad. Sci. U.S.A., 102, 634, 10.1073/pnas.0406278102
Prasad, 1999, Oligonucleotides tethered to a short polyguanylic acid stretch are targeted to macrophages: enhanced antiviral activity of a vesicular stomatitis virus-specific antisense oligonucleotide, Antimicrob. Agents Chemother., 43, 2689, 10.1128/AAC.43.11.2689
Puri, 2004, Telomere-based DNA damage responses: a new approach to melanoma, FASEB J., 18, 1373, 10.1096/fj.04-1774com
Qi, 2006, G-quadruplexes induce apoptosis in tumor cells, Cancer Res., 66, 11808, 10.1158/0008-5472.CAN-06-1225
Ramanathan, 1994, Characterization of the oligodeoxynucleotide-mediated inhibition of interferon-gamma-induced major histocompatibility complex class I and intercellular adhesion molecule-1, J. Biol. Chem., 269, 24564, 10.1016/S0021-9258(17)31429-1
Ramanathan, 1994, Inhibition of interferon-gamma-induced major histocompatibility complex class I expression by certain oligodeoxynucleotides, Transplantation, 57, 612, 10.1097/00007890-199402270-00023
Reyes-Reyes, 2008, Cell-surface nucleolin is a signal transducing P-selectin binding protein for human colon carcinoma cells, Exp. Cell Res., 314, 2212, 10.1016/j.yexcr.2008.03.016
Ritchie, C., Doran, B., Shah, K., Rowlinson-Busza, G., Courtenay-Luck, N., Jones, D., 2007. Combination of the aptamer AS1411 with paclitaxel or Ara-C produces synergistic inhibition of cancer cell growth. Proc. AACR 2007 (Meeting Abstract).
Rivory, 2006, The DNAzymes Rs6, Dz13, and DzF have potent biologic effects independent of catalytic activity, Oligonucleotides, 16, 297, 10.1089/oli.2006.16.297
Said, 2002, The anti-HIV cytokine midkine binds the cell surface-expressed nucleolin as a low affinity receptor, J. Biol. Chem., 277, 37492, 10.1074/jbc.M201194200
Saijo, 1997, Contiguous four-guanosine sequence in c-myc antisense phosphorothioate oligonucleotides inhibits cell growth on human lung cancer cells: possible involvement of cell adhesion inhibition, Jpn. J. Cancer Res., 88, 26, 10.1111/j.1349-7006.1997.tb00297.x
Scaggiante, 1998, Human cancer cell lines growth inhibition by GTn oligodeoxyribonucleotides recognizing single-stranded DNA-binding proteins, Eur. J. Biochem., 252, 207, 10.1046/j.1432-1327.1998.2520207.x
Scaggiante, 2006, Interaction of G-rich GT oligonucleotides with nuclear-associated eEF1A is correlated with their antiproliferative effect in haematopoietic human cancer cell lines, FEBS J., 273, 1350, 10.1111/j.1742-4658.2006.05143.x
Schwartz, 2008, G-rich oligonucleotides alter cell cycle progression and induce apoptosis specifically in OE19 esophageal tumor cells, Oligonucleotides, 18, 51, 10.1089/oli.2007.0109
Semenkovich, 1990, A protein partially expressed on the surface of HepG2 cells that binds lipoproteins specifically is nucleolin, Biochemistry, 29, 9708, 10.1021/bi00493a028
Shah, 2006, AS1411, a novel DNA aptamer as a potential treatment of acute myelogenous leukaemia (AML), Blood, 108, 564A, 10.1182/blood.V108.11.1996.1996
Shen, 2002, Antitumor mechanisms of oligodeoxynucleotides with CpG and polyG motifs in murine prostate cancer cells: decrease of NF-kappaB and AP-1 binding activities and induction of apoptosis, Antisense Nucleic Acid Drug Dev., 12, 155, 10.1089/108729002760220752
Shibata, 2002, Nuclear targeting by the growth factor midkine, Mol. Cell Biol., 22, 6788, 10.1128/MCB.22.19.6788-6796.2002
Shida, 1997, Quadruplex formation of oligonucleotides containing G clusters and their nuclease resistance, Nucleic Acids Symp. Ser., 37, 129
Shi, 2007, Nucleolin is a receptor that mediates antiangiogenic and antitumor activity of endostatin, Blood, 110, 2899, 10.1182/blood-2007-01-064428
Simonsson, 2002, c-myc Suppression in Burkitt's lymphoma cells, Biochem. Biophys. Res. Commun., 290, 11, 10.1006/bbrc.2001.6096
Sinclair, 2002, Cell surface-localized nucleolin is a eukaryotic receptor for the adhesin intimin-gamma of enterohemorrhagic Escherichia coli O157:H7, J. Biol. Chem., 277, 2876, 10.1074/jbc.M110230200
Skogen, 2006, Short G-rich oligonucleotides as a potential therapeutic for Huntington's Disease, BMC Neurosci., 7, 65, 10.1186/1471-2202-7-65
Soleimani-Meigooni, D.N., Mi, Y., Thomas, S.D., Jenson, A.B., Bates, P.J., 2007. Uncoupling of cell growth and division: An unusual mechanism of non-apoptotic cell death in leukemia cells treated with novel anticancer aptamer, AS1411. Proc. AACR 2007 (Meeting Abstract).
Sorokina, 2004, An acidic peptide sequence of nucleolin-related protein can mediate the attachment of calcium oxalate to renal tubule cells, J. Am. Soc. Nephrol., 15, 2057, 10.1097/01.ASN.0000133024.83256.C8
Soundararajan, 2008, The nucleolin targeting aptamer AS1411 destabilizes Bcl-2 messenger RNA in human breast cancer cells, Cancer Res., 68, 2358, 10.1158/0008-5472.CAN-07-5723
Srivastava, 1999, Molecular dissection of nucleolin's role in growth and cell proliferation: new insights, FASEB J., 13, 1911, 10.1096/fasebj.13.14.1911
Srividya, 2000, Selective activation of antitumor activity of macrophages by the delivery of muramyl dipeptide using a novel polynucleotide-based carrier recognized by scavenger receptors, Biochem. Biophys. Res. Commun., 268, 772, 10.1006/bbrc.2000.2216
Stein, 2001, The experimental use of antisense oligonucleotides: a guide for the perplexed, J. Clin. Invest., 108, 641, 10.1172/JCI13885
Storck, 2007, Functions of the histone chaperone nucleolin in diseases, Subcell. Biochem., 41, 125, 10.1007/1-4020-5466-1_7
Suzuki, 1999, Oligonucleotide aggregates bind to the macrophage scavenger receptor, Eur. J. Biochem., 260, 855, 10.1046/j.1432-1327.1999.00233.x
Takagi, 2005, Regulation of p53 translation and induction after DNA damage by ribosomal protein L26 and nucleolin, Cell, 123, 49, 10.1016/j.cell.2005.07.034
Tam, 1999, Increased potency of an aptameric G-rich oligonucleotide is associated with novel functional properties of phosphorothioate linkages, Antisense Nucleic Acid Drug Dev., 9, 289, 10.1089/oli.1.1999.9.289
Tate, 2006, Met-Independent Hepatocyte Growth Factor-mediated regulation of cell adhesion in human prostate cancer cells, BMC Cancer, 6, 197, 10.1186/1471-2407-6-197
Teng, 2007, AS1411 alters the localization of a complex containing protein arginine methyltransferase 5 and nucleolin, Cancer Res., 67, 10491, 10.1158/0008-5472.CAN-06-4206
Teng, Y., Pierce, W.M., Bates, P.J., 2007b. Proteomic studies of nucleolin complexes in prostate cancer cells treated with novel anticancer agent, AS1411. Proc. AACR 2007 (Meeting Abstract).
Tomita, 2003, Transcription factors as molecular targets: molecular mechanisms of decoy ODN and their design, Curr. Drug Targets, 4, 603, 10.2174/1389450033490803
Trieu, 2006, DNA motifs suppressing TLR9 responses, Crit. Rev. Immunol., 26, 527, 10.1615/CritRevImmunol.v26.i6.50
Tsolou, 2008, ssDNA fragments induce cell senescence by telomere uncapping, Exp. Gerontol., 43, 892, 10.1016/j.exger.2008.08.043
Tuteja, 1998, Nucleolin: a multifunctional major nucleolar phosphoprotein, Crit. Rev. Biochem. Mol. Biol., 33, 407, 10.1080/10409239891204260
Vlassov, 1994, Transport of oligonucleotides across natural and model membranes, Biochim. Biophys. Acta, 1197, 95, 10.1016/0304-4157(94)90001-9
Wang, 1998, A comparison of guanosine-quartet inhibitory effects versus cytidine homopolymer inhibitory effects on rat neointimal formation, Antisense Nucleic Acid Drug Dev., 8, 227, 10.1089/oli.1.1998.8.227
Weerasinghe, 2007, Inhibition of Stat3 activation and tumor growth suppression of non-small cell lung cancer by G-quartet oligonucleotides, Int. J. Oncol., 31, 129
Weerasinghe, 2008, T40214/PEI complex: a potent therapeutics for prostate cancer that targets STAT3 signaling, Prostate, 68, 1430, 10.1002/pros.20807
Wen, 2002, The Ff gene 5 single-stranded DNA-binding protein binds to the transiently folded form of an intramolecular G-quadruplex, Biochemistry, 41, 11438, 10.1021/bi020276e
White, 1996, Phosphorothioate-capped antisense oligonucleotides to Ras GAP inhibit cell proliferation and trigger apoptosis but fail to downregulate GAP gene expression, Biochem. Biophys. Res. Commun., 227, 118, 10.1006/bbrc.1996.1476
Wiegand, 1996, High-affinity oligonucleotide ligands to human IgE inhibit binding to Fc epsilon receptor I, J. Immunol., 157, 221, 10.4049/jimmunol.157.1.221
Wilson, 1998, Isolation of a fluorophore-specific DNA aptamer with weak redox activity, Chem. Biol., 5, 609, 10.1016/S1074-5521(98)90289-7
Wu, 2003, Selection of oligonucleotide aptamers with enhanced uptake and activation of human leukemia B cells, Hum. Gene Ther., 14, 849, 10.1089/104303403765701141
Wu, 2004, Necessity of oligonucleotide aggregation for toll-like receptor 9 activation, J. Biol. Chem., 279, 33071, 10.1074/jbc.M311662200
Wyatt, 1994, Combinatorially selected guanosine-quartet structure is a potent inhibitor of human immunodeficiency virus envelope-mediated cell fusion, Proc. Natl. Acad. Sci. U.S.A., 91, 1356, 10.1073/pnas.91.4.1356
Xu, 2001, Inhibition of DNA replication and induction of S phase cell cycle arrest by G-rich oligonucleotides, J. Biol. Chem., 276, 43221, 10.1074/jbc.M104446200
Yaar, 2007, Telomeric DNA induces apoptosis and senescence of human breast carcinoma cells, Breast Cancer Res., 9, R13, 10.1186/bcr1646
Yaswen, 1993, Effects of sequence of thioated oligonucleotides on cultured human mammary epithelial cells, Antisense Res. Dev., 3, 67, 10.1089/ard.1993.3.67
Yokoyama, 2007, Roles of mTOR and STAT3 in autophagy induced by telomere 3′ overhang-specific DNA oligonucleotides, Autophagy, 3, 496, 10.4161/auto.4602
Yoshida, 2008, Selection of DNA aptamers against insulin and construction of an aptameric enzyme subunit for insulin sensing, Biosens. Bioelectron., 5, 1116
Zhang, 2005, The immunostimulatory activity of CpG oligonucleotides on microglial N9 cells is affected by a polyguanosine motif, J. Neuroimmunol., 161, 68, 10.1016/j.jneuroim.2004.12.009